WE STRIVE TO PREVENT AND CURE DEMENTIA

For decades, Eisai has led the way in dementia research and development. Now we’re broadening our scope, taking a multi-dimensional, targeted path to our ultimate goal: prevention and a cure. Here’s a quick look at what we’re working on right now.

HERE’S OUR PRECISION APPROACH TO ACCELERATING NEUROLOGY ADVANCES

Building on 30 years of researching and understanding dementia, we’re striving to prevent and cure dementia and AD. Our precision approach to drug discovery research includes:

  1. Human biology: We're leveraging recent genetics research to explore using immunology to regulate processes and mechanisms in certain neurologic conditions.
  2. Translational sciences: By focusing on translational biomarker research early in the discovery process, our scientists can quickly identify which patients might respond to certain therapies.
  3. Collaboration-based research: We’re sharing our own research and working in partnerships with other experts to accelerate drug discovery and development.
  4. Diagnostics: We’re collaborating with other experts to develop and commercialize simple, cost-effective tools that can easily and accurately help health care professionals screen and diagnose AD.
A BLOOD TEST FOR ALZHEIMER’S?

A BLOOD TEST FOR ALZHEIMER’S?

We’re collaborating with Sysmex on a potential blood-based test for predicting amyloid pathology. This automated immune-assay system under investigation could also be utilized as a simpler and more cost-effective method to identify participants for clinical trials exploring a variety of AD therapies now in development.